Previous 10 | Next 10 |
2024-01-08 12:02:16 ET More on 10x Genomics 10x Genomics: Unveiling The Investment Potential 10x Genomics, Inc. (TXG) Q3 2023 Earnings Call Transcript BofA raises 10x Genomics to buy, cites fading headwinds 10x Genomics files patent lawsuit against rival Curi...
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results PR Newswire PLEASANTON, Calif. , Jan. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited se...
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
TORONTO, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) announces that the successful breakthrough of the Guajes Tunnel was completed last night. Breakthrough of the Guajes Tunnel represents a key de-risking milestone ...
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire PLEASANTON, Calif. , Dec. 21, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its mana...
10x Genomics Launches Xenium Catalyst Network PR Newswire Founding Network Members Will Accelerate Access to Proof-of-Concept Data for Prospective Xenium Customers Worldwide PLEASANTON, Calif. , Dec. 20, 2023 /PRNewswire/ -- 10x Genomics, Inc. , (...
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness PR Newswire A team of 10x Genomics scientists conducted a comprehensive analysis of human breast tumor microenvironments using all three of its indu...
High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint PR Newswire Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging pl...
2023-12-12 12:21:50 ET More on 10x Genomics 10x Genomics: Unveiling The Investment Potential 10x Genomics, Inc. (TXG) Q3 2023 Earnings Call Transcript 10x Genomics files patent lawsuit against rival Curio NanoString slips after 10x Genomics wins patent infrin...
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain PR Newswire PLEASANTON, Calif. , Dec. 7, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collabora...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...